Key Statistical Concepts in Clinical Trials for Pharma

This Brief discusses key statistical concepts that facilitate the inferential analysis of data collected from a group of individuals participating in a pharmaceutical clinical trial, the estimation of their clinical significance in the general population of individuals likely to be prescribed the dr...

Description complète

Enregistré dans:
Détails bibliographiques
Auteur principal: Turner, J. Rick. (Auteur, http://id.loc.gov/vocabulary/relators/aut)
Collectivité auteur: SpringerLink (Online service)
Format: Électronique eBook
Langue:English
Publié: New York, NY : Springer New York : Imprint: Springer, 2012.
Édition:1st ed. 2012.
Collection:SpringerBriefs in Pharmaceutical Science & Drug Development,
Sujets:
Accès en ligne:https://doi.org/10.1007/978-1-4614-1662-3
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
Description
Résumé:This Brief discusses key statistical concepts that facilitate the inferential analysis of data collected from a group of individuals participating in a pharmaceutical clinical trial, the estimation of their clinical significance in the general population of individuals likely to be prescribed the drug if approved, and the related decision-making that occurs at both the public health level (by regulatory agencies when deciding whether or not to approve a new drug for marketing) and the individual patient level (by physicians and their patients when deciding whether or not the patient should be prescribed a drug that is on the market). These concepts include drug safety and efficacy, statistical significance, clinical significance, and benefit-risk balance.
Description matérielle:IX, 61 p. 1 illus. online resource.
ISBN:9781461416623
ISSN:1864-8118